These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15598663)

  • 1. Collagen-induced platelet shape change is not affected by positive feedback pathway inhibitors and cAMP-elevating agents.
    Riondino S; Lotti LV; Cutini L; Pulcinelli FM
    J Biol Chem; 2005 Feb; 280(8):6504-10. PubMed ID: 15598663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convulxin induces platelet shape change through myosin light chain kinase and Rho kinase.
    Riondino S; Gazzaniga PP; Pulcinelli FM
    Eur J Biochem; 2002 Dec; 269(23):5878-84. PubMed ID: 12444976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
    Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
    Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.
    Wraith KS; Magwenzi S; Aburima A; Wen Y; Leake D; Naseem KM
    Blood; 2013 Jul; 122(4):580-9. PubMed ID: 23699602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway.
    Aburima A; Wraith KS; Raslan Z; Law R; Magwenzi S; Naseem KM
    Blood; 2013 Nov; 122(20):3533-45. PubMed ID: 24100445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2X1-mediated ERK2 activation amplifies the collagen-induced platelet secretion by enhancing myosin light chain kinase activation.
    Toth-Zsamboki E; Oury C; Cornelissen H; De Vos R; Vermylen J; Hoylaerts MF
    J Biol Chem; 2003 Nov; 278(47):46661-7. PubMed ID: 14500714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change.
    Paul BZ; Daniel JL; Kunapuli SP
    J Biol Chem; 1999 Oct; 274(40):28293-300. PubMed ID: 10497186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
    Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets.
    Walter U; Eigenthaler M; Geiger J; Reinhard M
    Adv Exp Med Biol; 1993; 344():237-49. PubMed ID: 8209791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of cAMP in human platelets inhibits thrombin- but not collagen-induced tyrosine phosphorylation.
    Smith JB; Dangelmaier C; Daniel JL
    Biochem Biophys Res Commun; 1993 Mar; 191(2):695-700. PubMed ID: 7681669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
    Puri RN; Colman RW
    J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet effects of caffeic acid due to Ca(2＋) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
    Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
    J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide.
    Jensen BO; Selheim F; Døskeland SO; Gear AR; Holmsen H
    Blood; 2004 Nov; 104(9):2775-82. PubMed ID: 15265792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADP-induced platelet shape change: an investigation of the signalling pathways involved and their dependence on the method of platelet preparation.
    Wilde JI; Retzer M; Siess W; Watson SP
    Platelets; 2000 Aug; 11(5):286-95. PubMed ID: 11030463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for platelet alphaIIb beta3 activation despite elevated cytosolic cAMP.
    Riondino S; Gazzaniga PP; Pulcinelli FM
    Thromb Haemost; 2001 Feb; 85(2):320-5. PubMed ID: 11246555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3beta in platelets.
    Hayashi H; Sudo T
    Thromb Haemost; 2009 Aug; 102(2):327-35. PubMed ID: 19652884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin-3-gallate has an anti-platelet effect in a cyclic AMP-dependent manner.
    Ok WJ; Cho HJ; Kim HH; Lee DH; Kang HY; Kwon HW; Rhee MH; Kim M; Park HJ
    J Atheroscler Thromb; 2012; 19(4):337-48. PubMed ID: 22498765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of collagen-induced arachidonic acid liberation by 1-(5-iodonaphthalene-1-sulphonyl)-1H-hexahydro-1,4-diazepine hydrochloride (ML-7), a myosin light chain kinase inhibitor, in washed rabbit platelets.
    Matsuoka I; Nakahata N; Nakanishi H
    Biochem Pharmacol; 1997 Nov; 54(9):1019-26. PubMed ID: 9374423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.